Adage Capital Partners’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Sell |
140,000
-325,000
| -70% | -$2.34M | ﹤0.01% | 793 |
|
|
2025
Q1 | $3.84M | Buy |
465,000
+140,000
| +43% | +$1.16M | 0.01% | 724 |
|
|
2024
Q4 | $12.9M | Buy |
325,000
+106,187
| +49% | +$4.23M | 0.02% | 545 |
|
|
2024
Q3 | $1.89M | Buy |
218,813
+18,813
| +9% | +$163K | ﹤0.01% | 785 |
|
|
2024
Q2 | $1.75M | Buy |
200,000
+101,420
| +103% | +$887K | ﹤0.01% | 785 |
|
|
2024
Q1 | $2.42M | Buy |
+98,580
| New | +$2.42M | ﹤0.01% | 764 |
|
|
2023
Q4 | – | Sell |
-48,931
| Closed | -$914K | – | 849 |
|
|
2023
Q3 | $914K | Hold |
48,931
| – | – | ﹤0.01% | 767 |
|
|
2023
Q2 | $1.19M | Hold |
48,931
| – | – | ﹤0.01% | 760 |
|
|
2023
Q1 | $1.07M | Sell |
48,931
-10,000
| -17% | -$219K | ﹤0.01% | 794 |
|
|
2022
Q4 | $1.4M | Hold |
58,931
| – | – | ﹤0.01% | 828 |
|
|
2022
Q3 | $1.62M | Hold |
58,931
| – | – | ﹤0.01% | 869 |
|
|
2022
Q2 | $1.78M | Hold |
58,931
| – | – | ﹤0.01% | 888 |
|
|
2022
Q1 | $3.17M | Buy |
+58,931
| New | +$3.17M | 0.01% | 871 |
|